Back to search

FORNY-3-Kommersialisering av FoUresultater

Development of a novel targeting MRI contrast agent to evaluate single kidney function in humans and in animals - additional funding

Awarded: NOK 0.95 mill.

Funding scheme:

FORNY-3-Kommersialisering av FoUresultater

Thematic Areas and Topics

No thematic area or topic related to the project